Aligos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Oct 23 | Buy€5,671,519 | Roche Holding AG | Company | 7,933,601 | €0.71 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 18,728 | 0.024% |
Individual Insiders | 4,388,728 | 5.62% |
VC/PE Firms | 6,102,770 | 7.81% |
Public Companies | 11,025,941 | 14.1% |
General Public | 13,909,652 | 17.8% |
Hedge Funds | 14,478,970 | 18.5% |
Institutions | 28,185,138 | 36.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 81.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,025,941 | €6.9m | 257% | no data | |||
7,264,147 | €4.5m | 84% | 0.15% | |||
7,214,823 | €4.5m | 0% | 0.13% | |||
6,102,770 | €3.8m | 0% | 0.14% | |||
3,664,013 | €2.3m | -29.1% | 0.03% | |||
3,547,030 | €2.2m | 0% | 0.19% | |||
2,882,216 | €1.8m | 0% | 0.01% | |||
2,844,681 | €1.8m | 0% | 1.53% | |||
2,320,381 | €1.4m | 0% | 0.5% | |||
2,189,847 | €1.4m | -34.2% | 0.16% | |||
2,149,297 | €1.3m | 1.35% | no data | |||
1,906,191 | €1.2m | -17.5% | 0.01% | |||
1,510,352 | €943.7k | 0% | no data | |||
1,297,000 | €810.4k | 0% | 0.21% | |||
1,255,000 | €784.2k | 36.4% | 0.11% | |||
1,147,762 | €717.2k | -0.21% | no data | |||
1,013,067 | €633.0k | 0.14% | no data | |||
808,260 | €505.0k | 65% | no data | |||
743,215 | €464.4k | 0% | 0.2% | |||
668,512 | €417.7k | 5.8% | 0.14% | |||
657,995 | €411.1k | 17.6% | no data | |||
394,064 | €246.2k | 0% | no data | |||
373,056 | €233.1k | 16.2% | no data | |||
303,755 | €189.8k | 2.57% | no data | |||
183,083 | €114.4k | 0% | no data |